James V. Caruso - Jan 25, 2022 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
President and CEO, Director
Signature
/s/ Christina Blakley, attorney-in-fact for James V. Caruso
Stock symbol
CLRB
Transactions as of
Jan 25, 2022
Transactions value $
$0
Form type
4
Date filed
1/27/2022, 03:05 PM
Next filing
Jan 18, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLRB Stock option (right to buy) Award $0 +1.42M $0.00 1.42M Jan 25, 2022 Common Stock 1.42M $0.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date.